夹子
发表于 2025-3-21 17:07:09
书目名称Controversies in Treating Diabetes影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0237696<br><br> <br><br>书目名称Controversies in Treating Diabetes影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0237696<br><br> <br><br>书目名称Controversies in Treating Diabetes网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0237696<br><br> <br><br>书目名称Controversies in Treating Diabetes网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0237696<br><br> <br><br>书目名称Controversies in Treating Diabetes被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0237696<br><br> <br><br>书目名称Controversies in Treating Diabetes被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0237696<br><br> <br><br>书目名称Controversies in Treating Diabetes年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0237696<br><br> <br><br>书目名称Controversies in Treating Diabetes年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0237696<br><br> <br><br>书目名称Controversies in Treating Diabetes读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0237696<br><br> <br><br>书目名称Controversies in Treating Diabetes读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0237696<br><br> <br><br>
CEDE
发表于 2025-3-21 21:22:58
Intensive Treatment and Complications of Diabetes,iovascular risks and therefore may have different effects on outcome. Metformin was the only oral anti-diabetic medication shown to decrease cardiovascular events independent of glycemic control. Thiazolidinediones improve insulin resistance and lower insulin concentrations, which may be beneficial
不足的东西
发表于 2025-3-22 04:06:41
Treatment of Type 2 Using Insulin,cent comparative data between the third National Health and Nutrition Examination Survey (NHANES III) (1988–1994) and the latest NHANES (1999–2000) strongly support this view. The report reveals certain changes in the pattern of insulin use in the USA, with a fall in the use of insulin monotherapy (
Intractable
发表于 2025-3-22 07:48:33
http://reply.papertrans.cn/24/2377/237696/237696_4.png
LINES
发表于 2025-3-22 10:54:44
http://reply.papertrans.cn/24/2377/237696/237696_5.png
Fissure
发表于 2025-3-22 15:31:36
Coming of Age for the Incretins,ve as a therapeutic agent for 2DM, but GLP-1 is rapidly destroyed in the body by the enzyme, dipeptidyl peptidase IV (DPP-IV). Clinical strategies therefore include (i) the development of metabolically stable activators of the GLP-1 receptor and (ii) inhibition of DPP-IV. Orally active DPP-IV inhibi
Fissure
发表于 2025-3-22 19:57:54
Polypills for Treatment of Type 2 Diabetes,of its aspects, any such polypill will encounter major obstacles. These are not only due to the size and weight of its formulation but also to the loss of therapeutic flexibility, which is mandatory to overcome acute metabolic derangements and to cope with intermittent increases in blood pressure. A
极大的痛苦
发表于 2025-3-22 23:03:12
http://reply.papertrans.cn/24/2377/237696/237696_8.png
CRUDE
发表于 2025-3-23 04:05:22
2523-3785 prehensive and timely, .Controversies in Treating Diabetes: Clinical and Research Aspects. is an essential reference for those treating and researching diabetes..978-1-61737-731-0978-1-59745-572-5Series ISSN 2523-3785 Series E-ISSN 2523-3793
Exclude
发表于 2025-3-23 07:04:25
Freud, the Subconscious and Virginia Woolf; a living donor eliminates waiting for a kidney, and the waiting time for a solitary pancreas at present is relatively short. The patient survival rates are high after either PTA, PAK or SPK transplants, at 3 years 93%;, 90% and 91% respectively, with corresponding graft survival (insulin-independe